Get started
Author

Debdutta Bandyopadhyay

Observed names: D Bandyopadhyay, D. Bandyopadhyay, DEBDUTTA BANDYOPADHYAY
ORCID: 0000-0001-9073-6289
Observed ORCID: 0000-0001-9073-6289
OpenAlex ID: A5014337755
Protein-Tyrosine Phosphatase 1B Complexes with the Insulin Receptor in Vivo and Is Tyrosine-phosphorylated in the Presence of Insulin
1997 · Debdutta Bandyopadhyay, Anasua Kusari, et al. · Journal of Biological Chemistry · 258
Physical Interaction between Epidermal Growth Factor Receptor and DNA-dependent Protein Kinase in Mammalian Cells
1998 · Debdutta Bandyopadhyay, Mahitosh Mandal, et al. · Journal of Biological Chemistry · 229
Estrogen Receptor Expression and Function in Long-Term Estrogen-Deprived Human Breast Cancer Cells1
1998 · Meei-Huey Jeng, Margaret A. Shupnik, et al. · Endocrinology · 175
Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes.
2002 · Debdutta Bandyopadhyay, Nihal A Okan, et al. · PubMed · 156
Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling.
2001 · J A Reed, E Bales, et al. · PubMed · 127
Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK)
1998 · Mahitosh Mandal, Debdutta Bandyopadhyay, et al. · Oncogene · 122
Overexpression of Histone Deacetylase 1 Confers Resistance to Sodium Butyrate–Mediated Apoptosis in Melanoma Cells through a p53-Mediated Pathway
2004 · Debdutta Bandyopadhyay, Anupam Mishra, et al. · Cancer Research · 111
The emerging role of epigenetics in cellular and organismal aging
2003 · Debdutta Bandyopadhyay, Estela E Medrano · Experimental Gerontology · 104
Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi
2007 · Debdutta Bandyopadhyay, Jonathan L. Curry, et al. · Aging Cell · 82
PDF
High Levels of Expression of p27KIP1 and Cyclin E in Invasive Primary Malignant Melanomas
1999 · Elise S. Bales, Cheryl Dietrich, et al. · Journal of Investigative Dermatology · 76
PDF
Marked impairment of protein tyrosine phosphatase 1B activity in adipose tissue of obese subjects with and without type 2 diabetes mellitus
1999 · Anthony Cheung, Jyotirmoy Kusari, et al. · Journal of Laboratory and Clinical Medicine · 76
Melanin Accumulation Accelerates Melanocyte Senescence by a Mechanism Involving p16INK4a/CDK4/pRB and E2F1
2000 · DEBDUTTA BANDYOPADHYAY, ESTELA E. MEDRANO · Annals of the New York Academy of Sciences · 74
The human melanocyte: a model system to study the complexity of cellular aging and transformation in non-fibroblastic cells
2001 · D. Bandyopadhyay, N. Timchenko, et al. · Experimental Gerontology · 72
Insulin-Induced Mitogen-Activated Protein (MAP) Kinase Phosphatase-1 (MKP-1) Attenuates Insulin-Stimulated MAP Kinase Activity: A Mechanism for the Feedback Inhibition of Insulin Signaling
1997 · Anasua B. Kusari, John Byon, et al. · Molecular Endocrinology · 61
PDF
Discovery of N-Cyano-sulfoximineurea Derivatives as Potent and Orally Bioavailable NLRP3 Inflammasome Inhibitors
2020 · Sameer Agarwal, Santosh Sasane, et al. · ACS Medicinal Chemistry Letters · 56
The Low Molecular Weight Cyclin E Isoforms Augment Angiogenesis and Metastasis of Human Melanoma Cells In vivo
2005 · Elise Bales, Lisa Mills, et al. · Cancer Research · 54
Analysis of Cellular Senescence in Culture In Vivo: The Senescence‐Associated β‐Galactosidase Assay
2005 · Debdutta Bandyopadhyay, Catherine Gatza, et al. · Current Protocols in Cell Biology · 27
Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor
2020 · Sameer Agarwal, Jignesh P. Pethani, et al. · Bioorganic & Medicinal Chemistry Letters · 26
Discovery of Orally Active, Potent, and Selective Benzotriazole‐Based PTP1B Inhibitors
2011 · Dipam Patel, Mukul Jain, et al. · ChemMedChem · 26
Interferon-α Signaling Promotes Nucleus-to-Cytoplasmic Redistribution of p95Vav, and Formation of a Multisubunit Complex Involving Vav, Ku80, and Tyk2
2000 · Liana Adam, Debdutta Bandyopadhyay, et al. · Biochemical and Biophysical Research Communications · 26
Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetes
2021 · Suresh Pola, Shailesh R. Shah, et al. · Bioorganic & Medicinal Chemistry · 15
Discovery of novel, potent and orally efficacious inhibitor of neutral amino acid transporter B0AT1 (SLC6A19)
2021 · Jigar Desai, Bhaumin Patel, et al. · Bioorganic & Medicinal Chemistry Letters · 14
ZYBT1, a potent, irreversible Bruton’s Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer
2020 · Krishnarup Ghoshdastidar, Hoshang Patel, et al. · Pharmacology Research & Perspectives · 13
Scientific and Regulatory Considerations in the Development of in Vitro Techniques for Toxicology
2017 · Mukul R. Jain, Debdutta Bandyopadhyay, et al. · Elsevier eBooks · 10
ZYKR1, a novel, potent, and peripherally selective kappa opioid receptor agonist reduces visceral pain and pruritus in animal models
2022 · Mukul R. Jain, Rakesh B. Patel, et al. · European Journal of Pharmacology · 9
Works count: 42
Citation count: 2,065
H-index: 20
I10-index: 24
Year
Topic
Type